Caroline's Feed
Mar 12, 2014

Novimmune appoints former Actelion manager as new CFO

ZURICH, March 12 (Reuters) – Privately-held Swiss biotech
company Novimmune, has appointed former Actelion
CFO Andrew Oakley as its new finance chief, increasing
expectations that the company will go public.

Oakley, a UK and Australian citizen who was chief financial
officer of Actelion for a decade, stepped down from the company
last August. He will take up his new role with immediate effect,
Novimmune said.

Mar 12, 2014

Adecco sees rising demand for temporary staff in Europe

ZURICH, March 12 (Reuters) – A nascent economic recovery in
Europe helped Adecco, the world’s largest staffing
agency by sales, beat fourth-quarter profit forecasts and
increase revenue for the first time in seven quarters.

Staffing companies benefit from moderate economic growth as
firms tend to hire temporary workers at the start of a recovery
when they are reluctant to commit to full-time hiring.

Mar 4, 2014

At Roche, ex-airline boss Franz promises continuity

BASEL (Reuters) – Outgoing Lufthansa (LHAG.DE: Quote, Profile, Research) boss Christoph Franz vowed to keep Roche (ROG.VX: Quote, Profile, Research) on its current course after shareholders overwhelmingly elected him as chairman of the Swiss drugmaker.

The 53-year-old is taking over as non-executive chairman of the world’s largest drugmaker by market capitalisation from Franz Humer who is stepping down after 16 years as CEO and chairman.

Mar 4, 2014

New Roche chairman promises continuity

BASEL (Reuters) – Outgoing Lufthansa (LHAG.DE: Quote, Profile, Research, Stock Buzz) boss Christoph Franz vowed to keep Roche (ROG.VX: Quote, Profile, Research, Stock Buzz) on its current course after shareholders overwhelmingly elected him as chairman of the Swiss drugmaker.

The 53-year-old is taking over as non-executive chairman of the world’s largest drugmaker by market capitalization from Franz Humer who is stepping down after 16 years as CEO and chairman.

Mar 3, 2014

New German chairmen change guard at Novartis, Roche

ZURICH, March 3 (Reuters) – When outgoing Lufthansa
chief executive Christoph Franz takes over as chairman
of Swiss drugmaker Roche on Tuesday, it could be the
start of a new era of less-frosty relations with arch-rival
Novartis.

The departure last year of Novartis architect and
CEO-turned-chairman Daniel Vasella marked the first step towards
a thawing-out process. He had upset Roche, the world’s biggest
cancer drug maker, by building up a 6.2 percent stake in the
group between 2001 and 2003, with the aim of merging the two
firms into one Swiss pharma giant.

Feb 25, 2014

Straumann bets on cheaper implants in difficult market

ZURICH, Feb 25 (Reuters) – The world’s largest maker of
dental implants, Straumann Holding Ltd, expects to grab
back market share from low-cost competitors by launching its
cheaper products in more markets this year.

Premium implant makers Straumann and local Swiss rival Nobel
Biocare have faced sluggish demand in Europe, their
main market, as cash-strapped consumers cut back on pricey
dental treatment or trade down to cheaper brands.

Feb 23, 2014

Swiss minister says EU threats over immigration overblown

ZURICH (Reuters) – Switzerland’s defense minister said it was “unthinkable” that his country’s accords with the European Union would be terminated as result of a referendum to curb immigration, saying threats of retaliation by the bloc were overblown.

Swiss voters this month narrowly backed a proposal to curtail immigration, a move that could violate a free movement of citizens pact with the 28-member bloc that came into force in 2002.

Feb 19, 2014

Swiss firms fret over immigration vote backlash

ZURICH (Reuters) – Nestled between the peaks of the Swiss Alps, the Hotel Schweizerhof has provided rooms for weary skiers and hikers for more than a century, profiting like scores of other businesses from Switzerland’s close ties to Europe.

But a shock vote last week to cap all immigration to the landlocked country and introduce quotas for those from the European Union, now threatens to cut the hotel off from the pool of workers on which it relies.

Feb 13, 2014

ABB lowers mid-term sales target on sluggish economy

ZURICH, Feb 13 (Reuters) – Swiss engineering group ABB
lowered its target for mid-term sales growth on
Thursday, blaming a slower-than-expected economic recovery and
weaker capital spending by its customers.

The company, which makes products ranging from power grids
for utilities to industrial robots, said sales growth this year
would be challenging as uncertainty in emerging markets, like
China, offset growth in the United States and parts of Europe.

Feb 12, 2014

Swiss put immigration worries aside to fete Russian-born snowboarder

ZURICH, Feb 12 (Reuters) – Days after Switzerland voted to impose new barriers to immigration, the surprise victory of a Russian-born snowboarder nicknamed “I-Pod” at the Olympic Games in Sochi has led to an ironic outpouring of national pride.

Images of 25-year-old Iouri Podladtchikov, who defeated favoured American Shaun White to win gold for Switzerland in the halfpipe, adorned the front pages of Swiss newspapers on Wednesday, jostling for space with headlines on the country’s plans to curtail an influx of foreigners.